News & Blog

News & Blog

  • Reset
Blog | Mar 28 2022

Meet The Community: Jakub

Community
Blog | Mar 28 2022

Meet The Community: Morgan Talevich

Community
News | Mar 28 2022

Stealth BioTherapeutics Receives Orphan Drug Designation from FDA for Elamipretide for the Treatment of Friedreich’s Ataxia

Industry News
Blog | Mar 14 2022

Meet The Community: Fatbardha Nuzi

Community
Blog | Mar 7 2022

Meet The Community: AJ Perez

Community
Blog | Feb 28 2022

Meet The Community: Denise Votta

Community
News | Feb 28 2022

Design Therapeutics Announces FDA Clearance of Investigational New Drug Application for First GeneTAC™ Molecule for Friedreich Ataxia

Industry News
Blog | Feb 21 2022

Meet The Community: Britanie Sutton

Community
News | Feb 16 2022

Lexeo Announces FDA Clearance of IND Application for LX2006 for Friedreich’s Ataxia Cardiomyopathy

Industry News
Blog | Feb 14 2022

Meet The Community: Richie Currier

Community
News | Feb 14 2022

Larimar Therapeutics Provides Update on CTI-1601 Clinical Program

Industry News